chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Headache, Myalgia, Neck mass
Clinical narrative: Difficulty in breathing; Knot on neck; Chest pain; Body aches; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty in breathing), NECK MASS (Knot on neck), CHEST PAIN (Chest pain), MYALGIA (Body aches) and HEADACHE (Headaches) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Shortness of breath.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty in breathing), NECK MASS (Knot on neck), CHEST PAIN (Chest pain), MYALGIA (Body aches) and HEADACHE (Headaches). At the time of the report, DYSPNOEA (Difficulty in breathing), NECK MASS (Knot on neck), CHEST PAIN (Chest pain), MYALGIA (Body aches) and HEADACHE (Headaches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  Treatment medications were unknown.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Difficulty in breathing; Knot on neck; Chest pain; Body aches; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty in breathing), NECK MASS (Knot on neck), CHEST PAIN (Chest pain), MYALGIA (Body aches) and HEADACHE (Headaches) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Shortness of breath.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty in breathing), NECK MASS (Knot on neck), CHEST PAIN (Chest pain), MYALGIA (Body aches) and HEADACHE (Headaches). At the time of the report, DYSPNOEA (Difficulty in breathing), NECK MASS (Knot on neck), CHEST PAIN (Chest pain), MYALGIA (Body aches) and HEADACHE (Headaches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  Treatment medications were unknown.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient did not take the second dose within the recommended dosing window; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient did not take the second dose within the recommended dosing window) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient did not take the second dose within the recommended dosing window). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient did not take the second dose within the recommended dosing window) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not reported.  Treatment information not reported.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second dose given to an unknown patient at 21 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given to an unknown patient at 21 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given to an unknown patient at 21 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given to an unknown patient at 21 days) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in the ears; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of TINNITUS (Ringing in the ears) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 immunisation.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced TINNITUS (Ringing in the ears). At the time of the report, TINNITUS (Ringing in the ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant or treatment medications were reported. The patient was seen by the ENT and was advised to proceed with the second dose.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. O16M20A and O12L20AOA) for COVID-19 vaccination.     No medical history reported by the patient.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), WARFARIN SODIUM (COUMADIN) and POTASSIUM for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Other) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 18-Feb-2021, PYREXIA (Fever) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: +20 (Inconclusive) Inconclusive.         No treatment information was provided.    This case was linked to INC.-MOD-2021-117907 (E2B Linked Report).; Sender's Comments: INC.-MOD-2021-117907:
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: Dizzy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) and FATIGUE (Tired) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (SUBOXONE), OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]), ALUMINIUM HYDROXIDE, MAGNESIUM TRISILICATE, SODIUM ALGINATE (PEPCID [ALUMINIUM HYDROXIDE;MAGNESIUM TRISILICATE;SODIUM ALGINATE]), ARIPIPRAZOLE, BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) and GABAPENTIN for an unknown indication.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced DIZZINESS (Dizzy) and FATIGUE (Tired). At the time of the report, DIZZINESS (Dizzy) and FATIGUE (Tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site hypoaesthesia
Clinical narrative: Numbness in arm of injection the size of a golfball; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (Numbness in arm of injection the size of a golfball) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DASATINIB MONOHYDRATE (SPRYCEL) and IBUPROFEN for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE HYPOAESTHESIA (Numbness in arm of injection the size of a golfball). At the time of the report, VACCINATION SITE HYPOAESTHESIA (Numbness in arm of injection the size of a golfball) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments. No treatment information was provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Feeling cold, Headache
Clinical narrative: sinus infection; feeling cold; throat soreness; chills; fever; throwed up couple of times; muscle pain,body is hurting; head was hurting every day; cough; difficulty to breath; "I am sick for the whole month.; runny nose; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DYSPNOEA (difficulty to breath), ILLNESS ("I am sick for the whole month.   ), RHINORRHOEA (runny nose) and FEELING COLD (feeling cold) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced COUGH (cough), DYSPNOEA (difficulty to breath), ILLNESS ("I am sick for the whole month.   ), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (throat soreness), CHILLS (chills), PYREXIA (fever), VOMITING (throwed up couple of times), MYALGIA (muscle pain,body is hurting) and HEADACHE (head was hurting every day). On 07-May-2021, the patient experienced FEELING COLD (feeling cold). On an unknown date, the patient experienced SINUSITIS (sinus infection). At the time of the report, COUGH (cough), DYSPNOEA (difficulty to breath), ILLNESS ("I am sick for the whole month.   ), RHINORRHOEA (runny nose), FEELING COLD (feeling cold), OROPHARYNGEAL PAIN (throat soreness), SINUSITIS (sinus infection), CHILLS (chills), PYREXIA (fever), VOMITING (throwed up couple of times), MYALGIA (muscle pain,body is hurting) and HEADACHE (head was hurting every day) outcome was unknown.            Treatment included amoxycillin antibiotics for10 days, for possible diagnosis as sinus infection.  No concomitant medication was provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-117971 (Patient Link).
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Myalgia, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: sinus infection; feeling cold; throat soreness; chills; fever; throwed up couple of times; muscle pain,body is hurting; head was hurting every day; cough; difficulty to breath; "I am sick for the whole month.; runny nose; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DYSPNOEA (difficulty to breath), ILLNESS ("I am sick for the whole month.   ), RHINORRHOEA (runny nose) and FEELING COLD (feeling cold) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced COUGH (cough), DYSPNOEA (difficulty to breath), ILLNESS ("I am sick for the whole month.   ), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (throat soreness), CHILLS (chills), PYREXIA (fever), VOMITING (throwed up couple of times), MYALGIA (muscle pain,body is hurting) and HEADACHE (head was hurting every day). On 07-May-2021, the patient experienced FEELING COLD (feeling cold). On an unknown date, the patient experienced SINUSITIS (sinus infection). At the time of the report, COUGH (cough), DYSPNOEA (difficulty to breath), ILLNESS ("I am sick for the whole month.   ), RHINORRHOEA (runny nose), FEELING COLD (feeling cold), OROPHARYNGEAL PAIN (throat soreness), SINUSITIS (sinus infection), CHILLS (chills), PYREXIA (fever), VOMITING (throwed up couple of times), MYALGIA (muscle pain,body is hurting) and HEADACHE (head was hurting every day) outcome was unknown.            Treatment included amoxycillin antibiotics for10 days, for possible diagnosis as sinus infection.  No concomitant medication was provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-117971 (Patient Link).
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis, Vomiting
Clinical narrative: sinus infection; feeling cold; throat soreness; chills; fever; throwed up couple of times; muscle pain,body is hurting; head was hurting every day; cough; difficulty to breath; "I am sick for the whole month.; runny nose; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DYSPNOEA (difficulty to breath), ILLNESS ("I am sick for the whole month.   ), RHINORRHOEA (runny nose) and FEELING COLD (feeling cold) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced COUGH (cough), DYSPNOEA (difficulty to breath), ILLNESS ("I am sick for the whole month.   ), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (throat soreness), CHILLS (chills), PYREXIA (fever), VOMITING (throwed up couple of times), MYALGIA (muscle pain,body is hurting) and HEADACHE (head was hurting every day). On 07-May-2021, the patient experienced FEELING COLD (feeling cold). On an unknown date, the patient experienced SINUSITIS (sinus infection). At the time of the report, COUGH (cough), DYSPNOEA (difficulty to breath), ILLNESS ("I am sick for the whole month.   ), RHINORRHOEA (runny nose), FEELING COLD (feeling cold), OROPHARYNGEAL PAIN (throat soreness), SINUSITIS (sinus infection), CHILLS (chills), PYREXIA (fever), VOMITING (throwed up couple of times), MYALGIA (muscle pain,body is hurting) and HEADACHE (head was hurting every day) outcome was unknown.            Treatment included amoxycillin antibiotics for10 days, for possible diagnosis as sinus infection.  No concomitant medication was provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-117971 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Cough, Malaise, Nasopharyngitis
Clinical narrative: Cough; No energy; Did not feel good; Sick to her stomach; Cold like symptoms; Rash on neck that she can still feel; Nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-May-2021 and was forwarded to Moderna on 11-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), ASTHENIA (No energy), MALAISE (Did not feel good), ABDOMINAL DISCOMFORT (Sick to her stomach) and NASOPHARYNGITIS (Cold like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (Cough), ASTHENIA (No energy), MALAISE (Did not feel good), ABDOMINAL DISCOMFORT (Sick to her stomach), NASOPHARYNGITIS (Cold like symptoms), RASH (Rash on neck that she can still feel) and NAUSEA (Nausea). At the time of the report, COUGH (Cough), ASTHENIA (No energy), MALAISE (Did not feel good), ABDOMINAL DISCOMFORT (Sick to her stomach), NASOPHARYNGITIS (Cold like symptoms), RASH (Rash on neck that she can still feel) and NAUSEA (Nausea) was resolving.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-119331 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow-up information received on 11-May-2021contains no new information. On 11-Jun-2021: Follow-up information received on 11-Jun-2021 contains updated event outcome.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Rash
Clinical narrative: Cough; No energy; Did not feel good; Sick to her stomach; Cold like symptoms; Rash on neck that she can still feel; Nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-May-2021 and was forwarded to Moderna on 11-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), ASTHENIA (No energy), MALAISE (Did not feel good), ABDOMINAL DISCOMFORT (Sick to her stomach) and NASOPHARYNGITIS (Cold like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (Cough), ASTHENIA (No energy), MALAISE (Did not feel good), ABDOMINAL DISCOMFORT (Sick to her stomach), NASOPHARYNGITIS (Cold like symptoms), RASH (Rash on neck that she can still feel) and NAUSEA (Nausea). At the time of the report, COUGH (Cough), ASTHENIA (No energy), MALAISE (Did not feel good), ABDOMINAL DISCOMFORT (Sick to her stomach), NASOPHARYNGITIS (Cold like symptoms), RASH (Rash on neck that she can still feel) and NAUSEA (Nausea) was resolving.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-119331 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow-up information received on 11-May-2021contains no new information. On 11-Jun-2021: Follow-up information received on 11-Jun-2021 contains updated event outcome.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Peripheral swelling, Tinnitus
Clinical narrative: Ringing in the ear involving both ears; Felt very tired; Arm was swollen really bad for 4 days; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen really bad for 4 days), TINNITUS (Ringing in the ear involving both ears) and FATIGUE (Felt very tired) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and Unknown) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen really bad for 4 days) and FATIGUE (Felt very tired). On 11-Apr-2021, the patient experienced TINNITUS (Ringing in the ear involving both ears). On 08-Apr-2021, FATIGUE (Felt very tired) had resolved. On 10-Apr-2021, PERIPHERAL SWELLING (Arm was swollen really bad for 4 days) had resolved. At the time of the report, TINNITUS (Ringing in the ear involving both ears) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 60 days since first dose; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (60 days since first dose) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (60 days since first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (60 days since first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications have been reported.  The patient had travel arrangements, which interfered with receiving the second dose.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pain, Pyrexia
Clinical narrative: Felt like the flu; Achy; Persistent low grade fever after second dose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like the flu), PAIN (Achy) and PYREXIA (Persistent low grade fever after second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Back pain. Concomitant products included FENTANYL CITRATE (NARCO) for Back pain.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like the flu), PAIN (Achy) and PYREXIA (Persistent low grade fever after second dose). On 30-Apr-2021, INFLUENZA LIKE ILLNESS (Felt like the flu) and PAIN (Achy) had resolved. At the time of the report, PYREXIA (Persistent low grade fever after second dose) had not resolved.            No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-117924 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Chills, Fatigue, Headache
Clinical narrative: A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable; Chills; Feeling tired; A lot of headache; A lot of nausea; Fever; Vomiting; Back pain; Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), CHEST PAIN (Chest pain), PRURITUS (A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable), CHILLS (Chills) and FATIGUE (Feeling tired) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter. .  Concomitant products included CELECOXIB (CELEXA [CELECOXIB]) for an unknown indication.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced BACK PAIN (Back pain), CHEST PAIN (Chest pain), CHILLS (Chills), FATIGUE (Feeling tired), HEADACHE (A lot of headache), NAUSEA (A lot of nausea), PYREXIA (Fever) and VOMITING (Vomiting). On 09-May-2021, the patient experienced PRURITUS (A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Chills, at an unspecified dose and frequency. On 10-May-2021, BACK PAIN (Back pain), CHEST PAIN (Chest pain), CHILLS (Chills), FATIGUE (Feeling tired), HEADACHE (A lot of headache), NAUSEA (A lot of nausea), PYREXIA (Fever) and VOMITING (Vomiting) had resolved. At the time of the report, PRURITUS (A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pruritus, Pyrexia, Vomiting
Clinical narrative: A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable; Chills; Feeling tired; A lot of headache; A lot of nausea; Fever; Vomiting; Back pain; Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), CHEST PAIN (Chest pain), PRURITUS (A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable), CHILLS (Chills) and FATIGUE (Feeling tired) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter. .  Concomitant products included CELECOXIB (CELEXA [CELECOXIB]) for an unknown indication.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced BACK PAIN (Back pain), CHEST PAIN (Chest pain), CHILLS (Chills), FATIGUE (Feeling tired), HEADACHE (A lot of headache), NAUSEA (A lot of nausea), PYREXIA (Fever) and VOMITING (Vomiting). On 09-May-2021, the patient experienced PRURITUS (A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Chills, at an unspecified dose and frequency. On 10-May-2021, BACK PAIN (Back pain), CHEST PAIN (Chest pain), CHILLS (Chills), FATIGUE (Feeling tired), HEADACHE (A lot of headache), NAUSEA (A lot of nausea), PYREXIA (Fever) and VOMITING (Vomiting) had resolved. At the time of the report, PRURITUS (A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Head discomfort, Headache, Influenza like illness
Clinical narrative: Hives; Flu like symptoms; Felt pretty bad; difficult to pick up her head; Chills; Weird headache behind the eyes; Nausea; Fever; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING ABNORMAL (Felt pretty bad), HEAD DISCOMFORT (difficult to pick up her head) and CHILLS (Chills) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hives. Concurrent medical conditions included Allergy NOS. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy NOS.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced URTICARIA (Hives), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING ABNORMAL (Felt pretty bad), HEAD DISCOMFORT (difficult to pick up her head), CHILLS (Chills), HEADACHE (Weird headache behind the eyes), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (throwing up). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING ABNORMAL (Felt pretty bad), HEAD DISCOMFORT (difficult to pick up her head), CHILLS (Chills), HEADACHE (Weird headache behind the eyes), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (throwing up) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-117926 (Patient Link).
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Urticaria, Vomiting
Clinical narrative: Hives; Flu like symptoms; Felt pretty bad; difficult to pick up her head; Chills; Weird headache behind the eyes; Nausea; Fever; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING ABNORMAL (Felt pretty bad), HEAD DISCOMFORT (difficult to pick up her head) and CHILLS (Chills) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hives. Concurrent medical conditions included Allergy NOS. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy NOS.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced URTICARIA (Hives), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING ABNORMAL (Felt pretty bad), HEAD DISCOMFORT (difficult to pick up her head), CHILLS (Chills), HEADACHE (Weird headache behind the eyes), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (throwing up). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING ABNORMAL (Felt pretty bad), HEAD DISCOMFORT (difficult to pick up her head), CHILLS (Chills), HEADACHE (Weird headache behind the eyes), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (throwing up) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-117926 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Illness, Insomnia, Nausea
Clinical narrative: Very sick from first shot; Very bad mark in upper arm where shot was given; When I touch my arm at injection site it is very very hot; Swelling on same arm; insomnia (wakes up every 30 minutes); diarrhea; stomach pain; extreme nausea; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very sick from first shot), VACCINATION SITE BRUISING (Very bad mark in upper arm where shot was given), VACCINATION SITE WARMTH (When I touch my arm at injection site it is very very hot), PERIPHERAL SWELLING (Swelling on same arm) and INSOMNIA (insomnia (wakes up every 30 minutes)) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced INSOMNIA (insomnia (wakes up every 30 minutes)), DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (stomach pain) and NAUSEA (extreme nausea). On 09-May-2021, the patient experienced ILLNESS (Very sick from first shot). 09-May-2021, the patient experienced VACCINATION SITE BRUISING (Very bad mark in upper arm where shot was given), VACCINATION SITE WARMTH (When I touch my arm at injection site it is very very hot) and PERIPHERAL SWELLING (Swelling on same arm). At the time of the report, ILLNESS (Very sick from first shot), VACCINATION SITE BRUISING (Very bad mark in upper arm where shot was given), VACCINATION SITE WARMTH (When I touch my arm at injection site it is very very hot), PERIPHERAL SWELLING (Swelling on same arm), INSOMNIA (insomnia (wakes up every 30 minutes)), DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (stomach pain) and NAUSEA (extreme nausea) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medication included Over the counter medications  Treatment medication included Zyrtec, Tylenol, TUMS, Equate Sleep Aid, nausea medication.  Action taken with mRNA-1273 Moderna vaccine was Not applicable   This case was linked to MOD-2021-074039 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up received on 11-MAY-2021 : second dose Lot number  was updated On 11-May-2021: Follow up received on 11-MAY-2021: second dose Anatomical location, treatment, new events were updated
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site bruising, Vaccination site warmth
Clinical narrative: Very sick from first shot; Very bad mark in upper arm where shot was given; When I touch my arm at injection site it is very very hot; Swelling on same arm; insomnia (wakes up every 30 minutes); diarrhea; stomach pain; extreme nausea; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very sick from first shot), VACCINATION SITE BRUISING (Very bad mark in upper arm where shot was given), VACCINATION SITE WARMTH (When I touch my arm at injection site it is very very hot), PERIPHERAL SWELLING (Swelling on same arm) and INSOMNIA (insomnia (wakes up every 30 minutes)) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced INSOMNIA (insomnia (wakes up every 30 minutes)), DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (stomach pain) and NAUSEA (extreme nausea). On 09-May-2021, the patient experienced ILLNESS (Very sick from first shot). 09-May-2021, the patient experienced VACCINATION SITE BRUISING (Very bad mark in upper arm where shot was given), VACCINATION SITE WARMTH (When I touch my arm at injection site it is very very hot) and PERIPHERAL SWELLING (Swelling on same arm). At the time of the report, ILLNESS (Very sick from first shot), VACCINATION SITE BRUISING (Very bad mark in upper arm where shot was given), VACCINATION SITE WARMTH (When I touch my arm at injection site it is very very hot), PERIPHERAL SWELLING (Swelling on same arm), INSOMNIA (insomnia (wakes up every 30 minutes)), DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (stomach pain) and NAUSEA (extreme nausea) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medication included Over the counter medications  Treatment medication included Zyrtec, Tylenol, TUMS, Equate Sleep Aid, nausea medication.  Action taken with mRNA-1273 Moderna vaccine was Not applicable   This case was linked to MOD-2021-074039 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up received on 11-MAY-2021 : second dose Lot number  was updated On 11-May-2021: Follow up received on 11-MAY-2021: second dose Anatomical location, treatment, new events were updated
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: patient who is 12 days past the recommended time to get the 2nd dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient who is 12 days past the recommended time to get the 2nd dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient who is 12 days past the recommended time to get the 2nd dose). On 11-May-2021, PRODUCT DOSE OMISSION ISSUE (patient who is 12 days past the recommended time to get the 2nd dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment details were provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016BZ1A) for COVID-19 vaccination.     No medical history information was provided.  Concomitant products included INSULIN, LOSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE, COLECALCIFEROL (VITAMIN D3), ALLOPURINOL, METOPROLOL, GABAPENTIN and METFORMIN for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 12-Apr-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment includes Tylenol
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hypokinesia, Loss of personal independence in daily activities, Pain
Clinical narrative: rectal pain crack of butt; unable to get up form bed; daughter had to help get me to the toilet and get up; very heavy pain felt like carry steel; feels like child bearing pain; fever 100.5; chills; fatigue; arm pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-May-2021 and was forwarded to Moderna on 12-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PROCTALGIA (rectal pain crack of butt), HYPOKINESIA (unable to get up form bed), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (daughter had to help get me to the toilet and get up), PAIN IN EXTREMITY (arm pain) and PAIN (very heavy pain felt like carry steel) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016CZ1A and 016BZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN for Diabetes, LOSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE, COLECALCIFEROL (VITAMIN D3), ALLOPURINOL, METOPROLOL, GABAPENTIN and METFORMIN for an unknown indication.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 08-May-2021, the patient experienced PROCTALGIA (rectal pain crack of butt), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (daughter had to help get me to the toilet and get up), PAIN (very heavy pain felt like carry steel), PAIN (feels like child bearing pain), PYREXIA (fever 100.5), CHILLS (chills) and FATIGUE (fatigue). 08-May-2021, the patient experienced HYPOKINESIA (unable to get up form bed). On 12-Apr-2021, PAIN IN EXTREMITY (arm pain) had resolved. On 08-May-2021, PYREXIA (fever 100.5) and CHILLS (chills) had resolved. On 10-May-2021, PROCTALGIA (rectal pain crack of butt), HYPOKINESIA (unable to get up form bed), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (daughter had to help get me to the toilet and get up), PAIN (very heavy pain felt like carry steel), PAIN (feels like child bearing pain) and FATIGUE (fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The Action taken with mRNA-1273(Modern covid-19 vaccine) was not applicable Treatment drug used is tylenol
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Proctalgia, Pyrexia
Clinical narrative: rectal pain crack of butt; unable to get up form bed; daughter had to help get me to the toilet and get up; very heavy pain felt like carry steel; feels like child bearing pain; fever 100.5; chills; fatigue; arm pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-May-2021 and was forwarded to Moderna on 12-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PROCTALGIA (rectal pain crack of butt), HYPOKINESIA (unable to get up form bed), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (daughter had to help get me to the toilet and get up), PAIN IN EXTREMITY (arm pain) and PAIN (very heavy pain felt like carry steel) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016CZ1A and 016BZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN for Diabetes, LOSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE, COLECALCIFEROL (VITAMIN D3), ALLOPURINOL, METOPROLOL, GABAPENTIN and METFORMIN for an unknown indication.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 08-May-2021, the patient experienced PROCTALGIA (rectal pain crack of butt), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (daughter had to help get me to the toilet and get up), PAIN (very heavy pain felt like carry steel), PAIN (feels like child bearing pain), PYREXIA (fever 100.5), CHILLS (chills) and FATIGUE (fatigue). 08-May-2021, the patient experienced HYPOKINESIA (unable to get up form bed). On 12-Apr-2021, PAIN IN EXTREMITY (arm pain) had resolved. On 08-May-2021, PYREXIA (fever 100.5) and CHILLS (chills) had resolved. On 10-May-2021, PROCTALGIA (rectal pain crack of butt), HYPOKINESIA (unable to get up form bed), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (daughter had to help get me to the toilet and get up), PAIN (very heavy pain felt like carry steel), PAIN (feels like child bearing pain) and FATIGUE (fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The Action taken with mRNA-1273(Modern covid-19 vaccine) was not applicable Treatment drug used is tylenol